-
摘要: 腺样囊性癌好发于头颈部唾液腺腺体,是一种恶性程度高、放化疗抵抗及预后较差的恶性肿瘤。腺样囊性癌临床病程进展缓慢,容易误诊,主要诊疗手段是在多学科会诊模式下的个体化精准治疗,即手术治疗和放化疗。腺样囊性癌容易复发和血道转移,以传统放化疗为基础的治疗手段在过去的30年里未取得令人满意的疗效,如何早发现、早诊断及早治疗是临床医师面临的需要迫切解决的难题。Abstract: Adenoid cystic carcinoma usually occurs in the salivary glands of the head and neck. It is a malignant tumor with a high degree of malignancy, resistance to radiotherapy and chemotherapy and poor prognosis. The clinical course of adenoid cystic carcinoma is slow and easy to be misdiagnosed. The main diagnosis and treatment means are individualized and precise treatment under the multi-disciplinary consultation mode, that is, surgical treatment and radiotherapy and chemotherapy. Adenoid cystic carcinoma is prone to relapse and hematologic metastasis, and the traditional radiotherapy and chemotherapy based therapies have not achieved satisfactory efficacy in the past three decades. How to detect, diagnose and treat early is an urgent task faced by clinicians.
-
Key words:
- oropharyngeal /
- adenoid cystic carcinoma /
- misdiagnosis /
- skin flap to repair
-
[1] Suárez C, Barnes L, Silver CE, et al. Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review[J]. Auris Nasus Larynx, 2016, 43(5): 477-484.
[2] Wang Y, Hu J, Wang Y, et al. EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells[J]. Cell Cycle, 2018, 17(12): 1457-1470. doi: 10.1080/15384101.2018.1489177
[3] Karimi A, Parhiz A, Eslamiamirabadi N, et al. Adenoid cystic carcinoma of buccal mucosa: A report of two rare cases and review of literature[J]. Clin Case Rep, 2020, 9(1): 23-30.
[4] Ahlem B, Manel N, Nouha BA, et al. High grade transformation of adenoid cystic carcinoma in the palate: Case report with review of literature[J]. Int J Surg Case Rep, 2021, 78: 162-166. doi: 10.1016/j.ijscr.2020.12.014
[5] Lahjaouj M, Berrada O, Rayhane A, et al. Advanced adenoid cystic carcinoma of maxillary sinus: Rare case report and review of literature[J]. Int J Surg Case Rep, 2021, 80: 105622.
[6] Liu X, Yang X, Zhan C, et al. Perineural Invasion in Adenoid Cystic Carcinoma of the Salivary Glands: Where We Are and Where We Need to Go[J]. Front Oncol, 2020, 10: 1493.
[7] Belulescu IC, Margaritescu C, Dumitrescu CI, et al. Adenoid Cystic Carcinoma of Salivary Gland: A Ten-Year Single Institute Experience[J]. Curr Health Sci J, 2020, 46(1): 56-65.
[8] Dou S, Li R, He N, et al. The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication[J]. Front Immunol, 2021, 12: 618367.
[9] Yang J, Zhou C, Wang Y, et al. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma[J]. BMC Ophthalmol, 2019, 19(1): 125.
[10] Sahara S, Herzog AE, Nör JE. Systemic therapies for salivary gland adenoid cystic carcinoma[J]. Am J Cancer Res, 2021, 11(9): 4092-4110.
[11] Tasoulas J, Divaris K, Theocharis S, et al. Impact of Tumor Site and Adjuvant Radiotherapy on Survival of Patients with Adenoid Cystic Carcinoma: A SEER Database Analysis[J]. Cancers(Basel), 2021, 13(4): 589.
[12] Dillon PM, Chakraborty S, Moskaluk CA, et al. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials[J]. Head Neck, 2016, 38(4): 620-627.
[13] Ran J, Qu G, Chen X, et al. Clinical features, treatment and outcomes in patients with tracheal adenoid cystic carcinoma: a systematic literature review[J]. Radiat Oncol, 2021, 16(1): 38.
[14] Cantù G. Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis[J]. Acta Otorhinolaryngol Ital, 2021, 41(4): 296-307. http://www.xueshufan.com/publication/3200919001